1,2-dimethylhydrazine multiple interactions ISO RGD:1618411 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSM3 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1618411 6480464 1, 2-Dimethylhydrazine results in decreased expression of ACSM3 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:62086 6480464 1-Naphthylisothiocyanate results in decreased expression of ACSM3 mRNA CTD PMID:30723492 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ACSM3 mRNA CTD PMID:20106945 17beta-estradiol decreases expression ISO RGD:1618411 6480464 Estradiol results in decreased expression of ACSM3 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ACSM3 mRNA CTD PMID:20660070 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1618411 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSM3 mRNA CTD PMID:21998131 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1618411 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1618411 6480464 Tetrachlorodibenzodioxin affects the expression of ACSM3 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1618411 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSM3 mRNA CTD PMID:19770486 , PMID:22539624 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62086 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSM3 mRNA, Tetrachlorodibenzodioxin results in decreased expression of SAH mRNA CTD PMID:18796159 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO RGD:62086 6480464 2 more ... CTD PMID:32109520 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1618411 6480464 3 more ... CTD PMID:19467301 3-chloropropane-1,2-diol decreases expression ISO RGD:62086 6480464 alpha-Chlorohydrin results in decreased expression of ACSM3 mRNA CTD PMID:28522335 4-hydroxyphenyl retinamide increases expression ISO RGD:1618411 6480464 Fenretinide results in increased expression of ACSM3 mRNA CTD PMID:28973697 5-fluorouracil multiple interactions EXP 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAH mRNA] CTD PMID:15016801 6-propyl-2-thiouracil increases expression ISO RGD:62086 6480464 Propylthiouracil results in increased expression of ACSM3 mRNA CTD PMID:22504374 , PMID:24780913 acetamide decreases expression ISO RGD:62086 6480464 acetamide results in decreased expression of ACSM3 mRNA CTD PMID:31881176 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of ACSM3 protein CTD PMID:20106945 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of ACSM3 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of ACSM3 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1618411 6480464 Aflatoxin B1 results in decreased expression of ACSM3 mRNA CTD PMID:19770486 ammonium chloride affects expression ISO RGD:62086 6480464 Ammonium Chloride affects the expression of ACSM3 mRNA CTD PMID:16483693 belinostat multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ACSM3 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:1618411 6480464 Benzoapyrene results in decreased expression of ACSM3 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation EXP 6480464 Benzoapyrene affects the methylation of ACSM3 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of ACSM3 mRNA CTD PMID:21632981 , PMID:32234424 benzo[a]pyrene increases expression ISO RGD:1618411 6480464 Benzoapyrene results in increased expression of ACSM3 mRNA CTD PMID:21569818 , PMID:22228805 bexarotene multiple interactions ISO RGD:62086 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of SAH mRNA CTD PMID:17630414 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1618411 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1618411 6480464 Diethylhexyl Phthalate results in increased expression of ACSM3 mRNA CTD PMID:30284816 bisphenol A decreases expression ISO RGD:62086 6480464 bisphenol A results in decreased expression of ACSM3 mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:62086 6480464 bisphenol A affects the expression of ACSM3 mRNA CTD PMID:30903817 bisphenol A affects methylation ISO RGD:1618411 6480464 bisphenol A affects the methylation of ACSM3 promoter CTD PMID:27334623 bisphenol A increases methylation ISO RGD:62086 6480464 bisphenol A results in increased methylation of ACSM3 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1618411 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of ACSM3 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1618411 6480464 Nanotubes more ... CTD PMID:25620056 chlorohydrocarbon multiple interactions ISO RGD:62086 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of ACSM3 mRNA CTD PMID:30744511 chromium(6+) affects expression ISO RGD:1618411 6480464 chromium hexavalent ion affects the expression of ACSM3 mRNA CTD PMID:28472532 ciglitazone multiple interactions EXP 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACSM3 mRNA CTD PMID:16197558 clofibric acid multiple interactions ISO RGD:62086 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SAH mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ACSM3 mRNA CTD PMID:22941251 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ACSM3 mRNA CTD PMID:20106945 , PMID:25562108 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of ACSM3 mRNA CTD PMID:27989131 dextran sulfate decreases expression ISO RGD:1618411 6480464 Dextran Sulfate results in decreased expression of ACSM3 protein CTD PMID:32272095 dextran sulfate multiple interactions ISO RGD:1618411 6480464 Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ACSM3 protein] CTD PMID:32272095 dibutyl phthalate decreases expression ISO RGD:1618411 6480464 Dibutyl Phthalate results in decreased expression of ACSM3 mRNA CTD PMID:21266533 dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of ACSM3 mRNA CTD PMID:28302478 dieldrin decreases expression ISO RGD:62086 6480464 Dieldrin results in decreased expression of ACSM3 mRNA CTD PMID:23153324 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ACSM3 mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:62086 6480464 Endosulfan results in decreased expression of ACSM3 mRNA CTD PMID:29391264 entinostat increases expression EXP 6480464 entinostat results in increased expression of ACSM3 mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ACSM3 mRNA CTD PMID:27188386 folic acid increases expression ISO RGD:1618411 6480464 Folic Acid results in increased expression of ACSM3 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1618411 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSM3 mRNA CTD PMID:22206623 furan increases methylation ISO RGD:62086 6480464 furan results in increased methylation of ACSM3 gene CTD PMID:22079235 genistein increases methylation ISO RGD:62086 6480464 Genistein results in increased methylation of ACSM3 gene CTD PMID:28505145 gentamycin decreases expression ISO RGD:62086 6480464 Gentamicins results in decreased expression of ACSM3 protein CTD PMID:21081137 , PMID:22061828 Heliotrine decreases expression ISO RGD:62086 6480464 heliotrine results in decreased expression of ACSM3 mRNA CTD PMID:32419051 Heliotrine decreases expression EXP 6480464 heliotrine results in decreased expression of ACSM3 mRNA CTD PMID:26100227 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1618411 6480464 indeno1 more ... CTD PMID:26377693 indole-3-methanol affects expression ISO RGD:62086 6480464 indole-3-carbinol affects the expression of ACSM3 mRNA CTD PMID:21396975 isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of SAH mRNA CTD PMID:20436886 lead diacetate affects expression ISO RGD:62086 6480464 lead acetate affects the expression of ACSM3 mRNA CTD PMID:21864555 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with resveratrol] results in increased expression of ACSM3 mRNA CTD PMID:26667767 metformin increases expression ISO RGD:62086 6480464 Metformin results in increased expression of ACSM3 mRNA CTD PMID:31324951 methimazole increases expression ISO RGD:62086 6480464 Methimazole results in increased expression of ACSM3 mRNA CTD PMID:22504374 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of ACSM3 mRNA CTD PMID:28001369 methylmercury chloride multiple interactions ISO RGD:62086 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of ACSM3 mRNA CTD PMID:30744511 N-nitrosodiethylamine multiple interactions ISO RGD:62086 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SAH mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SAH mRNA CTD PMID:17602206 , PMID:28943392 N-nitrosomorpholine decreases expression ISO RGD:62086 6480464 N-nitrosomorpholine results in decreased expression of ACSM3 mRNA CTD PMID:19716841 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of ACSM3 mRNA CTD PMID:24768652 O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of ACSM3 mRNA CTD PMID:32234424 orphenadrine affects expression ISO RGD:62086 6480464 Orphenadrine affects the expression of ACSM3 mRNA CTD PMID:23665939 panobinostat increases expression EXP 6480464 panobinostat results in increased expression of ACSM3 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1618411 6480464 Acetaminophen affects the expression of ACSM3 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ACSM3 mRNA CTD PMID:25704631 , PMID:29067470 perfluorohexanesulfonic acid decreases expression ISO RGD:1618411 6480464 perfluorohexanesulfonic acid results in decreased expression of ACSM3 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1618411 6480464 perfluorooctane sulfonic acid results in decreased expression of ACSM3 mRNA CTD PMID:21705711 perfluorooctanoic acid decreases expression ISO RGD:1618411 6480464 perfluorooctanoic acid results in decreased expression of ACSM3 mRNA CTD PMID:30657992 phenobarbital increases expression ISO RGD:1618411 6480464 Phenobarbital results in increased expression of ACSM3 mRNA CTD PMID:19270015 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of ACSM3 mRNA CTD PMID:27188386 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACSM3 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1618411 6480464 pirinixic acid results in increased expression of ACSM3 mRNA CTD PMID:18301758 , PMID:23811191 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:62086 6480464 Pregnenolone Carbonitrile results in decreased expression of ACSM3 mRNA CTD PMID:19162173 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ACSM3 mRNA CTD PMID:20660070 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ACSM3 mRNA CTD PMID:21632981 resveratrol multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with resveratrol] results in increased expression of ACSM3 mRNA CTD PMID:26667767 rotenone affects expression ISO RGD:62086 6480464 Rotenone affects the expression of ACSM3 mRNA CTD PMID:28374803 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 senecionine decreases expression EXP 6480464 senecionine results in decreased expression of ACSM3 mRNA CTD PMID:26100227 Senkirkine decreases expression EXP 6480464 senkirkine results in decreased expression of ACSM3 mRNA CTD PMID:26100227 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of ACSM3 mRNA, Silicon Dioxide results in decreased expression of ACSM3 mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenite affects methylation EXP 6480464 sodium arsenite affects the methylation of ACSM3 gene CTD PMID:28589171 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ACSM3 mRNA CTD PMID:29301061 sulforaphane decreases expression EXP 6480464 sulforaphane results in decreased expression of ACSM3 mRNA CTD PMID:26833863 tamoxifen multiple interactions ISO RGD:62086 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of SAH mRNA CTD PMID:17630414 tetrachloromethane decreases expression ISO RGD:1618411 6480464 Carbon Tetrachloride results in decreased expression of ACSM3 mRNA CTD PMID:27339419 , PMID:31919559 tetracycline decreases expression ISO RGD:1618411 6480464 Tetracycline results in decreased expression of ACSM3 mRNA CTD PMID:24489787 thioacetamide decreases expression ISO RGD:62086 6480464 Thioacetamide results in decreased expression of ACSM3 mRNA CTD PMID:23411599 thioacetamide multiple interactions ISO RGD:62086 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SAH mRNA CTD PMID:28943392 titanium dioxide decreases expression ISO RGD:1618411 6480464 titanium dioxide results in decreased expression of ACSM3 mRNA CTD PMID:23557971 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of ACSM3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ACSM3 mRNA CTD PMID:27188386 triphenyl phosphate decreases expression ISO RGD:62086 6480464 triphenyl phosphate results in decreased expression of ACSM3 mRNA CTD PMID:30589522 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ACSM3 mRNA CTD PMID:23179753 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of ACSM3 gene CTD PMID:29501571 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ACSM3 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ACSM3 mRNA CTD PMID:24383497 more ... vancomycin increases expression ISO RGD:1618411 6480464 Vancomycin results in increased expression of ACSM3 mRNA CTD PMID:18930951 vinclozolin increases expression ISO RGD:62086 6480464 vinclozolin results in increased expression of ACSM3 mRNA CTD PMID:23034163 vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ACSM3 mRNA CTD PMID:27188386 vorinostat increases expression EXP 6480464 vorinostat results in increased expression of ACSM3 mRNA CTD PMID:26272509 zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of ACSM3 mRNA CTD PMID:24714768